Skip to main content
. 2014 Oct 24;62(2):208–213. doi: 10.1002/pbc.25136

Fig. 2.

Fig. 2

Median (Q1, Q3) average weekly romiplostim dose (left y-axis) and median (Q1, Q3) platelet counts (right y-axis) are presented over time by 12-week intervals with the number of patients with available data underneath the x-axis.